Impact Dx Factor V Leiden and Factor II Genotyping Test regulatory update

Sequenom submitted 510(k) applications to FDA for the Impact Dx Factor V Leiden and Factor II Genotyping Test as an aid in the diagnosis of patients with suspected thrombophilia and its Impact Dx Sys...